PRECISION BIOSCIENCES INC (DTIL) Total liabilities 2018–2025
PRECISION BIOSCIENCES INC (DTIL) total liabilities at each fiscal year-end, per SEC filings.
$62.2MFY2025 · since FY2018: $98.6M → $62.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $62.2M | -22.3% |
| FY2024 | $80.0M | -43.2% |
| FY2023 | $140.9M | -20.7% |
| FY2022 | $177.7M | +47.7% |
| FY2021 | $120.3M | +13.8% |
| FY2020 | $105.7M | +9.1% |
| FY2019 | $96.9M | -1.7% |
| FY2018 | $98.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More DTIL financial trends
DTIL RevenueDTIL Net incomeDTIL Net marginDTIL Gross profitDTIL Gross marginDTIL Operating incomeDTIL Operating marginDTIL Operating cash flowDTIL Free cash flowDTIL Capital expendituresDTIL Return on equityDTIL Stock buybacksDTIL Dividends paidDTIL Total assetsDTIL Shareholders’ equityDTIL overview →